Centessa (CNTA) is down -8.4%, or -$2.49 to $27.08.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTA:
- Centessa Pharmaceuticals Appoints New CEO Amid Strategic Shift
- Strategic Leadership and Orexin Program Expansion Boost Centessa Pharmaceuticals’ Growth Potential
- Centessa CEO Saurabh Saha to step down, Mario Alberto Accardi to succeed
- Centessa assumed with an Outperform at Oppenheimer
- Centessa price target raised to $42 from $33 at B. Riley